Filter by: patients
What is Interferon beta-1a IM Injection?

Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 30–35% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 2348 758 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 54 11 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
General health 23 9 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Don't know 14 4 Efficacy_slight Efficacy_none Efficacy_cant_tell
Fatigue 14 2 Efficacy_major Efficacy_slight
Improve mobility 12 5 Efficacy_slight Efficacy_none Efficacy_cant_tell

See all 1496 patients currently taking Interferon beta-1a IM Injection

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
206
Moderate
275
Mild
243
None
61

Commonly reported side effects, conditions, and hospitalizations associated with Interferon beta-1a IM Injection

Flu like symptoms 309
Generalized muscle aches 225
Chills/fever 207
Body Aches 180
Headaches 118
Joint pain 89
See all 182 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Interferon beta-1a IM Injection. See all 81 dosages

  weekly 1 mg weekly 1 mcg weekly 30 mcg/0.5 mL every other week 22 mcg/0.5 mL weekly 30 mg weekly 30 mcg weekly 30 mcg/0.5 mL weekly 30 mcg/0.5 mL daily 30 mcg daily
  148 Number of Patients: 148 12 Number of Patients: 12 20 Number of Patients: 20 16 Number of Patients: 16 11 Number of Patients: 11 22 Number of Patients: 22 405 Number of Patients: 405 603 Number of Patients: 603 75 Number of Patients: 75 27 Number of Patients: 27  

Reported Stop Reasons

Why Patients Stopped Taking Interferon beta-1a IM Injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 622   Side effects too severe: 44%
Did not seem to work 482   Did not seem to work: 34%
Doctor's advice 428   Doctor's advice: 30%
Other 234   Other: 16%
Expense 68   Expense: 5%
Personal research 48   Personal research: 3%
Change in health plan coverage 28   Change in health plan coverage: 2%
Course of treatment ended 27   Course of treatment ended: 2%
Not indicated 24   Not indicated: 2%

See all 1364 patients who’ve stopped taking Interferon beta-1a IM Injection

Currently Taking Interferon beta-1a IM Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Interferon beta-1a IM Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Interferon beta-1a IM Injection

Always
651 83%
Usually
103 13%
Sometimes
10 1%
Never
21 3%

Burden

Difficulty being on treatment

Burden of Interferon beta-1a IM Injection

Very
130 17%
Somewhat
241 31%
A little
246 31%
Not at all
168 21%

Cost

Paid out of pocket

Cost of Interferon beta-1a IM Injection

$200+
64 11%
$100-199
44 8%
$50-99
68 12%
$25-49
127 22%
< $25
271 47%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.